International Stem Cell (ISCO) Accumulated Expenses (2010 - 2026)
International Stem Cell (ISCO) reported Accumulated Expenses of $969,000 for Q2 2026, up 48.8% from $651,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell posted Accumulated Expenses of $428,000, down 18.8% from FY2024.
- Accumulated Expenses has a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $527,000 in FY2024 (+8.7%), $485,000 in FY2023 (-4.5%), $508,000 in FY2022 (+25.7%) and $404,000 in FY2021 (+4.7%).
- The Q2 2026 figure ranks as the highest quarterly Accumulated Expenses since Q3 2015.
- Year over year, Accumulated Expenses gained in five of the last seven quarters, with growth averaging 8.6%.
- The high point for year-over-year Accumulated Expenses in five years was Q3 2022 (growth of 67.3%); the low point was Q3 2021 (a decline of 24.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.06 Bn | 1,139.65 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.89 Bn | 553.42 Bn | 17.26 Bn |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn |
| 4 | Merck | 377.44 Bn | 331.82 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.91 Bn | 267.90 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.03 Bn | 240.72 Bn | 12.86 Bn |
| 7 | Amgen | 241.88 Bn | 197.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn |
| 10 | International Stem Cell | 1.21 Mn | -2.76 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 969,000.00 |
| Dec 31, 2025 | 428,000.00 |
| Sep 30, 2025 | 452,000.00 |
| Jun 30, 2025 | 651,000.00 |
| Mar 31, 2025 | 608,000.00 |
| Dec 31, 2024 | 527,000.00 |
| Sep 30, 2024 | 475,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Mar 31, 2024 | 578,000.00 |
| Dec 31, 2023 | 485,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Jun 30, 2023 | 521,000.00 |
| Mar 31, 2023 | 632,000.00 |
| Dec 31, 2022 | 508,000.00 |
| Sep 30, 2022 | 475,000.00 |
| Jun 30, 2022 | 501,000.00 |
| Mar 31, 2022 | 505,000.00 |
| Dec 31, 2021 | 404,000.00 |
| Sep 30, 2021 | 284,000.00 |
| Jun 30, 2021 | 521,000.00 |
API Access
International Stem Cell Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();